title: Incidence of malignancy in Japanese patients with rheumatoid arthritis.
abstract: To determine the incidence of malignancy and site-specific malignancies in Japanese patients with rheumatoid arthritis (RA). In a prospective large observational cohort study named IORRA, 7,566 patients with RA were enrolled from April 2001 to April 2005 and were followed up to October 2005. Occurrence of malignancy was originally collected by patient reports of IORRA survey biannually from April 2001 to October 2005, and was confirmed by medical records. Standardized incidence rate (SIR) of the observed-to-expected cancer incidence and 95% confidence intervals (95% CI) were then calculated. Factors obtained at first enrollment in IORRA were assessed for association with risk of malignancy using the Cox proportional hazards model. A total of 177 malignancies in 173 patients (58 in men, 115 in women) were identified during the observation period of 25,567 person-years. The age- and sex-standardized incidence rate of malignancy was 437.1 (men, 706.8; women, 366.1) per 100,000 person-years. The SIR of malignancy was slightly excess (SIR 1.18, [95% CI 1.02-1.37]) in all patients, but 1.29 (95% CI 0.99-1.67) in men, and 1.13 (95% CI 0.94-1.36) in women. A significant excess of lymphoma (SIR 6.07, [95% CI 3.71-9.37]) and lung cancer (SIR 2.29, [95% CI 1.57-3.21]), whereas decreased incidence of colorectal cancer (SIR 0.49, [95% CI 0.26-0.83]), were found. Male gender and older age were identified as risk factors for malignancy. A slight excess in the incidence of overall malignancy and highly excess of lymphoma in Japanese RA patients was demonstrated.
authors.affiliation: Institute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjuku-ku, Tokyo 162-0054, Japan. tyamada@ior.twmu.ac.jp
authors.forename: Toru
authors.initials: T
authors.lastname: Yamada
authors.forename: Ayako
authors.initials: A
authors.lastname: Nakajima
authors.forename: Eisuke
authors.initials: E
authors.lastname: Inoue
authors.forename: Eiichi
authors.initials: E
authors.lastname: Tanaka
authors.forename: Atsuo
authors.initials: A
authors.lastname: Taniguchi
authors.forename: Shigeki
authors.initials: S
authors.lastname: Momohara
authors.forename: Hisashi
authors.initials: H
authors.lastname: Yamanaka
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000453:epidemiology* / Q000503:physiopathology; D015897:Comorbidity; D005260:Female; D006304:Health Status; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology*; D010146:Pain / Q000503:physiopathology; D016016:Proportional Hazards Models; D011446:Prospective Studies
references.citation: Ann Rheum Dis. 2006 Dec;65(12):1661-3
references.pmid: 16837491
references.citation: Arthritis Rheum. 2003 Dec 15;49(6):784-8
references.pmid: 14673964
references.citation: Rheumatology (Oxford). 2007 Feb;46(2):350-7
references.pmid: 16908509
references.citation: Arthritis Rheum. 2006 Mar;54(3):692-701
references.pmid: 16508929
references.citation: Semin Arthritis Rheum. 2008 Jun;37(6):388-97
references.pmid: 17977580
references.citation: Arthritis Rheum. 2006 Sep;54(9):2757-64
references.pmid: 16947774
references.citation: Med Oncol. 2009;26(1):1-9
references.pmid: 18461290
references.citation: Ann Rheum Dis. 1984 Apr;43(2):128-31
references.pmid: 6712287
references.citation: Arthritis Rheum. 2005 Mar;52(3):722-32
references.pmid: 15751097
references.citation: Scand J Rheumatol. 2010;39(5):360-7
references.pmid: 20476859
references.citation: Arthritis Rheum. 2007 May;56(5):1433-9
references.pmid: 17469100
references.citation: Ann Rheum Dis. 2005 Oct;64(10):1414-20
references.pmid: 15843454
references.citation: Int J Cancer. 2000 Nov 1;88(3):497-502
references.pmid: 11054684
references.citation: Mod Rheumatol. 2006;16(3):151-7
references.pmid: 16767553
references.citation: Ann Rheum Dis. 2005 May;64(5):699-703
references.pmid: 15695534
references.citation: J Rheumatol. 1997 Mar;24(3):445-51
references.pmid: 9058647
references.citation: Jpn J Clin Oncol. 2008 Sep;38(9):641-8
references.pmid: 18708647
references.citation: Int J Cancer. 2004 Jan 20;108(3):443-9
references.pmid: 14648712
references.citation: J Rheumatol. 2002 Jan;29(1):62-7
references.pmid: 11824973
references.citation: J Rheumatol. 1992 Sep;19(9):1462-5
references.pmid: 1433017
references.citation: Am J Hematol. 2007 Dec;82(12):1106-9
references.pmid: 17654684
references.citation: Mod Rheumatol. 2007;17(4):283-9
references.pmid: 17694260
references.citation: Semin Arthritis Rheum. 1999 Dec;29(3):148-58
references.pmid: 10622679
references.citation: J Rheumatol. 2007 Feb;34(2):322-31
references.pmid: 17117491
references.citation: Semin Arthritis Rheum. 1997 Jun;26(6):794-804
references.pmid: 9213378
references.citation: Arthritis Rheum. 1996 Feb;39(2):325-9
references.pmid: 8849387
references.citation: Pathol Res Pract. 2006;202(9):679-85
references.pmid: 16859835
references.citation: Arthritis Rheum. 2007 Mar;56(3):790-8
references.pmid: 17328051
references.citation: Arthritis Rheum. 1997 Sep;40(9):1580-6
references.pmid: 9324011
references.citation: Lung Cancer. 2008 Feb;59(2):266-9
references.pmid: 17673329
references.citation: Clin Rheumatol. 2006 Jul;25(4):498-505
references.pmid: 16267602
references.citation: Mod Rheumatol. 2008;18(2):165-9
references.pmid: 18317879
references.citation: J Rheumatol. 2008 Mar;35(3):387-93
references.pmid: 18260176
references.citation: Eur J Cancer. 1996 Sep;32A(10):1753-7
references.pmid: 8983286
references.citation: Semin Arthritis Rheum. 2007 Aug;37(1):31-8
references.pmid: 17360028
references.citation: Arthritis Res Ther. 2008;10(2):R45
references.pmid: 18433475